Oncotherm

What Oncotherm does

Oncotherm is a private, for-profit medical device company headquartered in Budaörs, Hungary. Founded in 1988, the company develops, manufactures, and markets devices used in the treatment of cancer. It is not publicly listed and operates with a reported headcount of 1-10 employees, a notably small corporate footprint relative to its 35+ years of operating history.

The company's product portfolio is centered on cancer treatment devices, but detailed product specifications, underlying technology (e.g., whether the devices rely on hyperthermia, thermal ablation, radiofrequency, or another modality), regulatory clearances (CE marking, FDA 510(k), etc.), and pricing structure are not present in the available source material. The company's primary website (oncotherm.com) was inaccessible at time of research and returned only a verification/wait page, which limits independent verification of first-party claims about product features, clinical indications, and geographic reach.

The 1-10 employee headcount at the corporate level, combined with 35+ years of operating history and an internationally marketed medical device product, suggests that Oncotherm likely operates a lean parent entity focused on R&D, regulatory affairs, and intellectual property, with manufacturing, sales, and clinical deployment potentially executed through regional distributors, licensed affiliates, or contract manufacturers. However, this distribution structure is not directly confirmed in the input data. No management team, board composition, partnerships, distribution agreements, funding history, certifications, patents, or revenue disclosures are present in the available source material, representing a significant data gap for any investment analysis.

Name

Oncotherm

Website

https://oncotherm.com

Company type

Private

Founded year

1988

Headcount range

1–10 employees

Short description

Oncotherm is a private Hungarian medical device company, founded in 1988 and headquartered in Budaörs, that develops, manufactures, and markets cancer treatment devices for oncology healthcare providers globally.

Ownership category

akta.pro rank

Product category

Oncological Hyperthermia Medical Devices

akta.pro primary industry

Medical Oncology (HLAKAFAB)

Keywords

• Medical devices
• Cancer treatment
• Oncology equipment
• Clinical hyperthermia systems
• Tumor therapy devices

Headquarters

HQ city

Budaörs

HQ country

Hungary

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Core offering

Oncotherm (also styled OncoTherm) is a medical device company that develops, manufactures, and markets cancer treatment devices. The company's core products are physical therapy systems used by hospitals and oncology clinics to deliver oncological treatment to cancer patients, leveraging proprietary hyperthermia-based technology for tumor therapy.

Differentiator

Problem solved

Functional benefit

Products and services

• Cancer treatment devices

Ideal customer profiles1 record

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Broad incumbents

• Elekta: Elekta is a global leader in radiation therapy and radiosurgery equipment. As a broad incumbent in the oncology device market, it competes for hospital capital budgets and clinical workflow share that Oncotherm also depends on.
• IBA (Ion Beam Applications): IBA is a major provider of proton therapy and other radiation oncology solutions, competing for the same clinical oncology hardware budgets that drive demand for adjunctive devices such as Oncotherm's hyperthermia systems.
• Accuray: Accuray develops the CyberKnife and TomoTherapy platforms for radiation oncology. While not a hyperthermia peer, it competes for the same hospital radiotherapy capital allocation and is therefore a relevant broad incumbent.
• Varian Medical Systems: Varian, now part of Siemens Healthineers, is a dominant global radiation oncology hardware and software provider. It is a broad incumbent whose installed base and clinical relationships set the competitive context in which Oncotherm's adjunctive devices are deployed.

Emerging players

• RefleXion Medical: RefleXion develops biology-guided radiotherapy systems for cancer treatment, representing an emerging technology in the oncology device space that shares Oncotherm's hospital-based customer profile.
• Nanobiotix: Nanobiotix develops nanoparticle-based radio-enhancer therapies for oncology. While it is a product company rather than a device manufacturer, it operates in the same emerging 'device-plus-drug' oncology enhancement space as hyperthermia.

Direct peers

• Pyrexar Medical: Pyrexar (formerly BSD Medical) manufactures hyperthermia delivery systems used as adjuncts to radiotherapy and chemotherapy for cancer treatment, directly overlapping with Oncotherm's core product category and clinical use case.
• Andromedic: Andromedic develops and markets hyperthermia and other physiotherapy devices, including oncology-adjacent systems, making it a direct niche peer to Oncotherm in the hyperthermia device segment.
• Celsius42: Celsius42 produces localized hyperthermia systems for cancer treatment and shares Oncotherm's niche of device-based locoregional hyperthermia combined with standard oncology modalities.
• Dr. Sennewald Medizintechnik: Dr. Sennewald Medizintechnik is a German specialty manufacturer of medical hyperthermia systems for cancer therapy, addressing the same clinical niche and customer base as Oncotherm.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights4 records

Customer concentration

• LinkedInlinkedin.com/company/oncotherm-kft.

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Oncotherm